Beth Skwarecki is Lifehacker’s Senior Health Editor, and holds certifications as a personal trainer and weightlifting coach. She has been writing about health for over 10 years. I’ve always been drawn ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Suzanne is a content marketer, writer, ...

Discover the latest articles and news in related subjects. In many cancer studies, the main outcome under assessment is the time to an event of interest. The generic name for the time is survival time ...

Retrospective Analysis of Carboplatin and Paclitaxel as Initial Second-Line Therapy for Recurrent Epithelial Ovarian Carcinoma: Application Toward a Dynamic Disease State Model of Ovarian Cancer ...

Phase 1 and 2 clinical trials of the BRAF kinase inhibitor vemurafenib (PLX4032) have shown response rates of more than 50% in patients with metastatic melanoma with the BRAF V600E mutation. We ...

More Americans die of lung cancer than from the next two different cancers combined. Lung cancer is also one of the most challenging to treat. One estimate states that fewer than 1 in 5 people ...

Survival depends on many factors. No one can tell you exactly how long you will live. Below are general statistics based on large groups of people. Remember, they can’t tell you what will happen in ...